Quick Answer
Xenetic Biosciences, Inc. reported Research And Development Expense of $3.07 million for the year ending 2025.
- Xenetic Biosciences, Inc. showed a decrease of -6.8% in Research And Development Expense from 2024 to 2025.
- This data is from Xenetic Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $622.1 thousand | Q2 2013: $956.4 thousand | Q3 2013: $1.04 million | Q1 2014: $564.9 thousand | Q2 2014: $1.03 million | Q3 2014: $1.91 million | Q1 2015: $1.04 million | Q2 2015: $555.7 thousand | Q3 2015: $816.3 thousand | Q1 2016: $429.3 thousand | Q2 2016: $2.21 million | Q3 2016: $891.8 thousand | Q1 2017: $1.22 million | Q2 2017: $873.8 thousand | Q3 2017: $884.8 thousand | Q1 2018: $706.3 thousand | Q2 2018: $927.1 thousand | Q3 2018: $735.9 thousand | Q1 2019: $463.8 thousand | Q2 2019: $487.5 thousand | Q3 2019: $3.52 million | Q1 2020: $359.7 thousand | Q2 2020: $307.9 thousand | Q3 2020: $573.1 thousand | Q1 2021: $629.7 thousand | Q2 2021: $524.6 thousand | Q3 2021: $780.2 thousand | Q1 2022: $1.10 million | Q2 2022: $2.08 million | Q3 2022: $398.8 thousand | Q1 2023: $595.3 thousand | Q2 2023: $903.2 thousand | Q3 2023: $1.02 million | Q1 2024: $944.3 thousand | Q2 2024: $933.8 thousand | Q3 2024: $368.0 thousand | Q1 2025: $879.0 thousand | Q2 2025: $656.6 thousand | Q3 2025: $756.5 thousand.
- Over the full 13 years of available data (2013 to 2025), Xenetic Biosciences, Inc.'s Research And Development Expense has declined by 0.5%.
- Historical annual values: Fiscal year 2025: $3.07 million | Fiscal year 2024: $3.29 million | Fiscal year 2023: $3.49 million | Fiscal year 2022: $4.77 million | Fiscal year 2021: $3.16 million | Fiscal year 2020: $1.73 million | Fiscal year 2019: $4.89 million | Fiscal year 2018: $2.88 million | Fiscal year 2017: $4.06 million | Fiscal year 2016: $43.74 million | Fiscal year 2015: $3.43 million | Fiscal year 2014: $6.32 million | Fiscal year 2013: $3.08 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: